Tuesday Talks: How to Build a Company and Tackle the Toughest Diseases

Tuesday, January 31, 2023

Presented by Seema Kumar, CEO, Cure

Join us as pioneering entrepreneur, investor, and former Genzyme executive Jim Geraghty shares his extensive and ground-breaking experiences building and fostering Biotech companies large and small—and how they overcame the many hurdles faced in developing treatments for rare but serious diseases.

Jim will be talking about his new book, Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology (Cold Spring Laboratory Press), which Nature called “[An] informative, sometimes passionate account [that] mixes patients’ struggles with business, medicine, politics and technology.”

About the book

There are thousands of diseases classified as “rare” because they afflict only a small number of people. These patient groups were long ignored by a pharmaceutical industry that judged them too small to provide a return on the investment needed to develop an effective remedy. Forty years ago, a revolution started that transformed the prospects of patients with rare diseases. This book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen, and it tells deeply personal stories of patients and parents willing to risk new, untried therapies.

Be sure to take a glance at the Forward of Jim’s book which you can access for free in the following link, http://orphandrugrevolution.com/